Home › Flu › Utah › Salt Lake City
Flu clinical trials in Salt Lake City, UT
4 studies for Flu are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
RecruitingPhase 3Healthy volunteers welcome
- GSK Investigational Site, Salt Lake City
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
RecruitingPhase 1/2Healthy volunteers welcome
- CenExel JRB - Salth Lake City- Site Number : 8400009, Salt Lake City
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Salt Lake City
- Research Site, Salt Lake City
A Study to Learn About mRNA Vaccines Against Influenza in Adults
RecruitingPhase 2Healthy volunteers welcome
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
About Flu
The flu can cause serious illness in people over 65, babies, and people with certain chronic illnesses. The best way to prevent the flu is to get a vaccine.
Flu trials in other cities
- Atlanta, GA9 studies
- Washington, DC7 studies
- Chicago, IL5 studies
- Philadelphia, PA5 studies
- Charlottesville, VA5 studies
- Baltimore, MD4 studies
- Hialeah, FL4 studies
- Houston, TX4 studies
- Seattle, WA4 studies
- Durham, NC4 studies
- St. Louis, MO4 studies
- Rochester, NY3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)28 studies
- Breast Cancer27 studies
- Melanoma21 studies
- Lung Cancer21 studies
- Colorectal Cancer21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Heart Failure17 studies
- Acute Myeloid Leukemia17 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.